Drawing for LIPAD

USPTO serial 86945392

LIPAD

Reviewed by CopyMark Law Group

Reg. 5760160Status 705Registered
Filing date
Status date
Registration date
May 28, 2019
Examiner
HESIK, APRIL ANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with LIPAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joe McKinney Muncy

Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.125 S. Royal StreetAlexandria, VA 22314United States

Goods and services

ClassDescriptionStatusFirst use
005[ Allergy medications; antibacterial pharmaceuticals; antibiotic preparations; antibiotics; antifungal preparations; anti-cancer preparations; anti-diabetic preparations; anti-inflammatories; aspirin; lipid-based preparations for medical or clinical use; cardiovascular treatment preparations; cells for medical or clinical use; chemotherapeutics; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicated skin care preparations; ophthalmic preparations; pain relief medication; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; radioactive pharmaceutical preparations for therapeutic use ]SECTION 8 - CANCELLED—
042Biochemical research and development; biomedical research services; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; chemical, biochemical, biological and bacteriological research and analysis; development of pharmaceutical preparations and medicines; medical and scientific research, namely, conducting clinical trials for others; medical research services relating to diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; product development in the field of biopharmaceutical; pharmaceutical research services; pharmaceutical drug development services; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; technical research in the field of drug delivery systemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 31, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 31, 2025C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 31, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 16, 2024E815TEAS SECTION 8 & 15 RECEIVED—
May 28, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 23, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 28, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 12, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 6, 2019PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 29, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 29, 2019ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 28, 2019OTHECASE RETURNED TO EXAMINATION—
Jan 22, 2019ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Jan 22, 2019PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Jan 14, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
Jan 14, 2019ERTITEAS RESPONSE TO PETITION INQUIRY LETTER—
Jan 14, 2019PILMPETITION INQUIRY LETTER ISSUED—
Jan 14, 2019APETASSIGNED TO PETITION STAFF—
Nov 6, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 2, 2018EX3GSOU EXTENSION 3 GRANTED—
Nov 2, 2018EXT3SOU EXTENSION 3 FILED—
Nov 2, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 2, 2018TPDRTEAS PETITION TO DIRECTOR RECEIVED—
May 18, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 16, 2018EX2GSOU EXTENSION 2 GRANTED—
May 16, 2018EXT2SOU EXTENSION 2 FILED—
May 16, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 18, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 16, 2017EX1GSOU EXTENSION 1 GRANTED—
Nov 16, 2017EXT1SOU EXTENSION 1 FILED—
Nov 16, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 16, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 21, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 27, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 20, 2017ALIEASSIGNED TO LIE—
Dec 27, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2016GAUNNOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED—
Sep 12, 2016GAUDNOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED—
Sep 12, 2016NAUDREPORT UNRESPONSIVE AMENDMENT - COMPLETED—
Sep 8, 2016AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Sep 8, 2016PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 28, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 28, 2016DOCKASSIGNED TO EXAMINER—
Mar 23, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 22, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance